Enhancing Postharvest Quality and Shelf Life of Strawberries through Advanced Coating Technologies: A Comprehensive Investigation of Chitosan and Glycine Betaine Nanoparticle Treatments.

The application of natural polymer-based coatings presents a viable approach to prolong the longevity of fruits and tissue damage. This study investigates the impact of treatments involving glycine betaine (GB), chitosan (CTS), and chitosan-coated glycine betaine nanoparticles (CTS-GB NPs) on preserving the quality and reducing decay in strawberry fruits. The fruits were subjected to treatments with GB (1 mM), CTS (0.1%), CTS-GB NPs (0.1%), or distilled water at 20 °C for 5 min, followed by storage at 4 °C for 12 days. The results indicate that CTS and CTS-GB NPs treatments resulted in the highest tissue firmness, total anthocyanin content, and ascorbate peroxidase activity, while exhibiting the lowest decay percentage and weight loss, as well as reduced malondialdehyde levels at the end of storage. GB, CTS, and CTS-GB NPs treatments demonstrated elevated catalase activity and antioxidant capacity, coupled with lower electrolyte leakage and hydrogen peroxide levels. These treatments did not significantly differ from each other but were markedly different from the control. The results substantiate that CTS and CTS-GB NPs treatments effectively preserve strawberry quality and extend storage life by bolstering antioxidant capacity and mitigating free radical damage.

Mutational spectrum of autosomal recessive limb-girdle muscular dystrophies in a cohort of 112 Iranian patients and reporting of a possible founder effect.

BACKGROUND: Limb-girdle muscular dystrophies are a group of genetically heterogeneous diseases that are inherited in both autosomal dominant (LGMDD) and autosomal recessive forms (LGMDR), the latter is more common especially in populations with high consanguineous marriages like Iran. In the present study, we aimed to investigate the genetic basis of patients who are suspicious of being affected by LGMDR. DNA samples of 60 families suspected of LGMD were extracted from their whole blood. Four short tandem repeat (STR) markers for each candidate genes related to LGMD R1 (calpain3 related)- R6 (δ-sarcoglycan-related) were selected, and all these 24 STRs were applied in two sets of multiplex PCR. After autozygosity mapping, Sanger sequencing and variant analysis were done. Predicting identified variants' effect was performed using in-silico tools, and they were interpreted according to the American College of Medical Genomics and Genetics (ACMG) guideline. MLPA was used for those patients who had large deletions. Fresh muscle specimens were taken from subjects and were evaluated using the conventional panel of histochemical stains. RESULTS: forty out of sixty families showed homozygote haplotypes in CAPN3, DYSF, SGCA, and SGCB genes. The exons and intron-exon boundaries of the relevant genes were sequenced and totally 38 mutations including CAPN3 (n = 15), DYSF (n = 9), SGCB (n = 11), and SGCA (n = 3) were identified. Five out of them were novel. The most prevalent form of LGMDs in our study was calpainopathy followed by sarcoglycanopathy in which beta-sarcoglycanopathy was the most common form amongst them. Exon 2 deletion in the SGCB gene was the most frequent mutation in this study. We also reported evidence of a possible founder effect in families with mutations in DYSF and SGCB genes. We also detected a large consanguineous family suffered from calpainopathy who showed allelic heterogeneity. CONCLUSIONS: This study can expand our knowledge about the genetic spectrum of LGMD in Iran, and also suggest the probable founder effects in some Iranian subpopulations which confirming it with more sample size can facilitate our genetic diagnosis and genetic counseling.